Background Skeletal muscle wasting is an extremely common feature in patients with heart
failure, affecting approximately 20% of ambulatory patients with even higher values during …

Aims To assess the prevalence and clinical impact of reductions in the skeletal muscle mass
of patients with chronic heart failure (HF). Chronic HF is accompanied by co-morbidities that …

Background Muscle wasting can be accelerated by chronic diseases such as heart failure
and is one of the major causes of disability, morbidity, and mortality in this population. We …

Heart failure (HF) remains a major challenge in Western countries with up to 2% of the
population being affected. Co-morbidities have a huge impact on the clinical course and on …

Background Inadequate nutritional status has been linked to poor outcomes in patients with
heart failure (HF). Skeletal muscle wasting affects about 20% of ambulatory patients with HF …

Body wasting is a serious complication that affects a large proportion of patients with heart
failure. Muscle wasting, also known as sarcopenia, is the loss of muscle mass and strength …

Patients with heart failure are frequently limited in their exercise capacity. Although this
clinical phenomenon is mostly attributed to the failing myocardium, the effects of skeletal …

Background Cachexia, characterized by loss of muscle with or without loss of fat mass, is a
poor prognostic factor in patients with heart failure (HF). However, there is limited …

The relationship between muscle wasting and mortality risk in the general population
remains unclear. Our study was conducted to examine and quantify the associations …

The last several years have seen increasing interest in understanding cachexia, muscle
wasting, and physical frailty across the broad spectrum of patients with cardiovascular …